Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring (ODM), today told DirectorsTalk about the launch of TruFlow, a the new, wider beam, single patient disposable probe in the UK and USA.
The reconfigured probe tip design creates a wider ultrasound beam at the focal point in the aorta. Extensive clinical testing in UK hospitals, has confirmed most doctors find that the new probes are easier to focus and that they maintain focus substantially better, even when the patient’s position is changed.
The TruFlow probe has been used in all new evaluations in the USA since November 2015.
Ewan Phillips, Deltex Medical’s Chief Executive, commented: “The new wider beam of the TruFlow probes are a major step-forward for Deltex as making the proven ODM technology even easier to use, reduces perceived barriers to change in clinical practice and further reduces the clinical support needed before new customers become independent users.”
